Mountain View, CA– We know how much air pressure is in our tires. We are informed well before the gasoline in our car runs out. We can even request products to be automatically shipped to our households with the touch of a button when they start to run low. So why is it that we aren’t taking these sorts of preventative measures for our own health and well-being? Why is healthcare a reactive measure that we take when things start to crumble beneath us and not something we feel prepared for? These are questions that Google Life Sciences has been exploring since its inception. And with their latest rebranding effort under parent company Alphabet, Verily will seek to uncover critical insights into the massive question of how we can intelligently blend science, data and health.
Amongst the projects that we know of that Verily is already undertaking include:
- a glucose-sensing contact lens in partnership with Novartis subsidiary Alcon
- a multiple sclerosis research project with Biogen
- a “cancer sensing pill” powered by nanoparticles
- a smart eating utensil for people with Parkinson’s disease (Lift Labs)
Verily isn’t joining this mission alone. They will be joining a fleet of other companies that are embarking on this growing effort to use big data in order to understand complex diseases. If they are successful, expect to continue to see healthcare innovations that help patients receive more preventative and less reactive solutions.